| Crystalline solids SR Vippagunta, HG Brittain, DJW Grant Advanced drug delivery reviews 48 (1), 3-26, 2001 | 1933 | 2001 |
| Crystal structures of drugs: advances in determination, prediction and engineering S Datta, DJW Grant Nature Reviews Drug Discovery 3 (1), 42-57, 2004 | 712 | 2004 |
| Pharmaceutical hydrates RK Khankari, DJW Grant Thermochimica acta 248, 61-79, 1995 | 614 | 1995 |
| Solubility behavior of organic compounds DJW Grant, T Higuchi | 480 | 1990 |
| Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation CH Gu, V Young Jr, DJW Grant Journal of pharmaceutical sciences 90 (11), 1878-1890, 2001 | 415 | 2001 |
| Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility D Zhou, GGZ Zhang, D Law, DJW Grant, EA Schmitt Journal of pharmaceutical sciences 91 (8), 1863-1872, 2002 | 411 | 2002 |
| Theory and origin of polymorphism DJW Grant Polymorphism in pharmaceutical solids, 1-34, 1999 | 406 | 1999 |
| Non-linear van't Hoff solubility-temperature plots and their pharmaceutical interpretation DJW Grant, M Mehdizadeh, AHL Chow, JE Fairbrother International journal of pharmaceutics 18 (1-2), 25-38, 1984 | 405 | 1984 |
| Influence of crystal structure on the tableting properties of sulfamerazine polymorphs C Sun, DJW Grant Pharmaceutical research 18, 274-280, 2001 | 351 | 2001 |
| Solid-state characterization of nifedipine solid dispersions SR Vippagunta, KA Maul, S Tallavajhala, DJW Grant International Journal of Pharmaceutics 236 (1-2), 111-123, 2002 | 302 | 2002 |
| Influence of water activity in organic solvent+ water mixtures on the nature of the crystallizing drug phase. 1. Theophylline H Zhu, C Yuen, DJW Grant International Journal of Pharmaceutics 135 (1-2), 151-160, 1996 | 251 | 1996 |
| Solid-state pharmaceutical chemistry SR Byrn, RR Pfeiffer, G Stephenson, DJW Grant, WB Gleason Chemistry of materials 6 (8), 1148-1158, 1994 | 251 | 1994 |
| Hydrogen bonding in sulfonamides DA Adsmond, DJW Grant Journal of pharmaceutical sciences 90 (12), 2058-2077, 2001 | 198 | 2001 |
| Identifying the stable polymorph early in the drug discovery–development process JM Miller, BM Collman, LR Greene, DJW Grant, AC Blackburn Pharmaceutical development and technology 10 (2), 291-297, 2005 | 178 | 2005 |
| Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes AR Sheth, JW Lubach, EJ Munson, FX Muller, DJW Grant Journal of the American Chemical Society 127 (18), 6641-6651, 2005 | 173 | 2005 |
| Influence of elastic deformation of particles on Heckel analysis C Sun, DJW Grant Pharmaceutical development and technology 6 (2), 193-200, 2001 | 169 | 2001 |
| Crystallization and transitions of sulfamerazine polymorphs GGZ Zhang, C Gu, MT Zell, RT Burkhardt, EJ Munson, DJW Grant Journal of pharmaceutical sciences 91 (4), 1089-1100, 2002 | 159 | 2002 |
| Effects of polymorphism and solid-state solvation on solubility and dissolution rate HG Brittain, DJR Grant, PB Myrdal Polymorphism in pharmaceutical solids, 448-492, 2018 | 156 | 2018 |
| Effects of initial particle size on the tableting properties of L-lysine monohydrochloride dihydrate powder C Sun, DJW Grant International journal of pharmaceutics 215 (1-2), 221-228, 2001 | 154 | 2001 |
| Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data CH Gu, DJW Grant Journal of pharmaceutical sciences 90 (9), 1277-1287, 2001 | 149 | 2001 |
